Clinical Study
HOMA-AD in Assessing Insulin Resistance in Lean Noncirrhotic HCV Outpatients
Table 5
Main results of the studies with reference to HCV, IR, and adiponectin.
| Author, year, ref | HCV () | Controls () | Confounding factors (%) | HOMA-IR | Adiponectin | (HCV versus controls) | (HCV versus controls) |
| | 11 | | Cirrhosis (0) | No information | Similar |
Lu et al., 2005 [23] | 10 HBV | 21 | DM (0) | | | | Obesity—no information |
| | 30 | 30 | Cirrhosis (0) | Similar | Similar |
Aksõz et al., 2008 [22] | DM (0) | | Obesity (0) |
| | 30 | 30 HBV | Cirrhosis (0) | Similar | Similar |
Tanaka et al., 2008 [25] | DM (0) | | Obesity (0) |
| | 154 | 75 | Cirrhosis (0) | Higher in HCV | Similar |
Cua et al., 2007 [26] | DM (0) | | Obesity—no information |
| | 51 | 24 | Cirrhosis (0) | No information | Similar |
Tiftikci et al., 2009 [27] | DM—no information | | Obesity—no information |
|
Zografos et al., 2008 [28] | 83 | 43 | No information | No information | No information |
| | 81 | 40 | Cirrhosis (34) | Higher in HCV | Higher in HCV |
Hung et al., 2009 [21] | F3/F4 | | DM (0) | | Obesity—no information |
| | 94 | 29 | Cirrhosis (0) | Higher in HCV | Higher in HCV | Present study/2011 | DM (0) | | Obesity (0) |
|
|